Nintedanib in children and adolescents with fibrosing interstitial lung disease: the InPedILD trial

被引：0
|
作者：
Matthias, Griese [1 ]
Robin, Deterding [2 ,3 ]
Lisa, Young R. [4 ]
Emily, DeBoer M. [2 ,3 ]
David, Warburton [5 ,6 ]
Steven, Cunningham [7 ]
Nicolaus, Schwerk [8 ]
Kevin, Flaherty R. [9 ]
Kevin, Brown K. [10 ]
Mihaela, Dumistracel [11 ]
Elvira, Erhardt [12 ]
Julia, Bertulis [12 ]
Martina, Gahlemann [13 ]
Susanne, Stowasser [14 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Hauner Childrens Hosp, German Ctr Lung Res DZL, Munich, Germany
[2] Univ Colorado Denver, Sect Pediat Pulm & Sleep Med, Dept Pediat, Denver, CO USA
[3] Childrens Hosp Colorado, Aurora, CO USA
[4] Childrens Hosp Philadelphia, Div Pulm & Sleep Med, Philadelphia, PA USA
[5] Childrens Hosp Los Angeles, Los Angeles, CA USA
[6] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[7] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
[8] Hannover Med Sch, Clin Pediat Pulmonol Allergol & Neonatol, Hannover, Germany
[9] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[10] Natl Jewish Hlth, Dept Med, Denver, CO USA
[11] Boehringer Ingelheim Pharma GmbH Co KG, Ingelheim, Germany
[12] Boehringer Ingelheim Pharma GmbH Co KG, Biberach, Germany
[13] Boehringer Ingelheim Schweiz GmbH, Basel, Switzerland
[14] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
来源：
KLINISCHE PADIATRIE | 2023年 / 235卷 / 02期
关键词：
D O I：
10.1055/s-0043-1761556
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
P46
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [1] Nintedanib in children and adolescents with fibrosing interstitial lung disease: the InPedILD trial
    Deterding, R.
    Young, L. R.
    Deboer, E. M.
    Warburton, D.
    Cunningham, S.
    Schwerk, N.
    Flaherty, K. R.
    Brown, K. K.
    Dumistracel, M.
    Erhardt, E.
    Bertulis, J.
    Gahlemann, M.
    Stowasser, S.
    Griese, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] Nintedanib in children and adolescents with fibrosing interstitial lung disease: the InPedILD* trial**
    Griese, Autoren M.
    Deterding, R.
    Young, L.
    DeBoer, E.
    Warburton, D.
    Cunningham, S.
    Schwerk, N.
    Flaherty, K.
    Brown, K.
    Dumistracel, M.
    Erhardt, E.
    Bertulis, J.
    Gahlemann, M.
    Stowasser, S.
    PNEUMOLOGIE, 2023, 77 : S53 - S53
  • [3] Nintedanib in children and adolescents with fibrosing interstitial lung diseases
    Deterding, Robin
    Young, Lisa R.
    DeBoer, Emily M.
    Warburton, David
    Cunningham, Steven
    Schwerk, Nicolaus
    Flaherty, Kevin R.
    Brown, Kevin K.
    Dumistracel, Mihaela
    Erhardt, Elvira
    Bertulis, Julia
    Gahlemann, Martina
    Stowasser, Susanne
    Griese, Matthias
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (02)
  • [4] Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease
    Deterding, Robin
    Griese, Matthias
    Deutsch, Gail
    Warburton, David
    DeBoer, Emily M.
    Cunningham, Steven
    Clement, Annick
    Schwerk, Nicolaus
    Flaherty, Kevin R.
    Brown, Kevin K.
    Voss, Florian
    Schmid, Ulrike
    Schlenker-Herceg, Rozsa
    Verri, Daniela
    Dumistracel, Mihaela
    Schiwek, Marilisa
    Stowasser, Susanne
    Tetzlaff, Kay
    Clerisme-Beaty, Emmanuelle
    Young, Lisa R.
    ERJ OPEN RESEARCH, 2021, 7 (02)
  • [5] Nintedanib in children and adolescents with fibrosing interstitial lung diseases (vol 61, 2201512, 2023)
    Deterding, R.
    Young, L. R.
    DeBoer, E. M.
    Warburton, D.
    Cunningham, S.
    Schwerk, N.
    Flaherty, K. R.
    Brown, K. K.
    Dumistracel, M.
    Erhardt, E.
    Bertulis, J.
    Gahlemann, M.
    Stowasser, S.
    Griese, M.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (05)
  • [6] Study Design of a Phase III, Randomized, Placebo-Controlled Trial of Nintedanib in Children and Adolescents with Clinically Significant Fibrosing Interstitial Lung Disease (ILD)
    Young, L.
    Brown, K. K.
    Griese, M.
    Deutsch, G.
    Warburton, D.
    DeBoer, E.
    Cunningham, S.
    Clement, A. F.
    Schwerk, N.
    Flaherty, K. R.
    Voss, F.
    Schmid, U.
    Schlenker-Herceg, R.
    Verri, D.
    Stowasser, S.
    Clerisme-Beaty, E. M.
    Deterding, R. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [7] Circulating biomarkers in children and adolescents with fibrosing interstitial lung disease (ILD)
    Deterding, Robin
    Brown, Kevin K.
    Cunningham, Steven
    Deboer, Emily M.
    Griese, Matthias
    Schwerk, Nicolaus
    Young, Lisa R.
    Ittrich, Carina
    Schlange, Thomas
    Gahlemann, Martina
    Warburton, David
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [8] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Kao, Jui-Hung
    Huang, Hsin-Tuan
    Li, Ko-Jen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 780 - 781
  • [9] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Flaherty, K. R.
    Wells, A. U.
    Cottin, V
    Devaraj, A.
    Walsh, S. L. F.
    Inoue, Y.
    Richeldi, L.
    Kolb, M.
    Tetzlaff, K.
    Stowasser, S.
    Coeck, C.
    Clerisme-Beaty, E.
    Rosenstock, B.
    Quaresma, M.
    Haeufel, T.
    Goeldner, R-G
    Schlenker-Herceg, R.
    Brown, K. K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18): : 1718 - 1727
  • [10] Nintedanib in progressive fibrosing interstitial lung diseases
    Hadjiski, D.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (04): : 393 - 394
12345